Cargando…

SAT-LB13 Clinical Utility of 21-Deoxycortisol in Congenital Adrenal Hyperplasia

Introduction Congenital Adrenal Hyperplasia (CAH) is most often caused by mutation of the 21-hydroxylase gene (CYP21), which results in underproduction of cortisol with overproduction of precursor steroids and their metabolites by the adrenal glands. Historically the most common biomarker used for d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Curtin, Bill, Chandler, Donald Walt, Holmquist, Brett
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Pediatric Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209013/ http://dx.doi.org/10.1210/jendso/bvaa046.2067

Ejemplares similares

SAT-LB049 Identification of a Rare Mutation in Congenital Adrenal Hyperplasia Patients in Costa Rica
por: Umaña Calderón, Andrés, et al.
Publicado: (2019)

Serum 21-Deoxycortisol for Diagnosis of Nonclassic Congenital Adrenal Hyperplasia in Women With Androgen Excess
por: Ng, Jennifer L, et al.
Publicado: (2023)

SAT-296 Congenital Adrenal Hyperplasia Presenting as Central Precocious Puberty
por: Malineni, Vikas, et al.
Publicado: (2019)

SUN-LB11 What Is the Value of Clinical Suspicion in Neonatal Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency (CAH 21OHD)?
por: Fernández, María Sanz, et al.
Publicado: (2020)

SAT-LB050 Congenital Adrenal Hyperplasia Newborn Screening Protocols Differ Widely in the US: A Survey by the Differences/Disorders of Sex Development Translational Research Network (DSD-TRN)
por: Speiser, Phyllis, et al.
Publicado: (2019)

SAT-097 Early Adiposity Rebound in Youth with Congenital Adrenal Hyperplasia Predicts Childhood Obesity and Adiposity in Adolescence
por: Bhullar, Gagandeep, et al.
Publicado: (2020)

SAT-087 Identifying Distinct Facial Dysmorphology in Youth with Congenital Adrenal Hyperplasia Using Deep Learning Techniques
por: Guo, Xiao, et al.
Publicado: (2020)

MON-LB049 Central Precocious Puberty as a Presenting Sign of Non-Classical Congenital Adrenal Hyperplasia: Prevalence and Clinical Characteristics
por: de Vries, Liat, et al.
Publicado: (2019)

SAT-286 A Previously Undescribed Combination of Aromatase Deficiency and Non-Classical Congenital Adrenal Hyperplasia in an Hispanic Teenage Male
por: Gottesman, Bethany, et al.
Publicado: (2019)

A Liquid Chromatography/Tandem Mass Spectometry Profile of 16 Serum Steroids, Including 21-Deoxycortisol and 21-Deoxycorticosterone, for Management of Congenital Adrenal Hyperplasia
por: Fiet, Jean, et al.
Publicado: (2017)

SUN-071 Prenatal and Post-Natal Influence of Androgens in the Psychosexual Development in Individuals with 21-hydroxylase Congenital Adrenal Hyperplasia
por: Batista, Rafael Loch, et al.
Publicado: (2020)

The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Pignatelli, Duarte, et al.
Publicado: (2019)

SAT-098 The Impact of 17-OHP Cutoffs Determination in a Public Newborn Screening Program for Congenital Adrenal Hyperplasia in Southern Brazil: A Three Years’ Experience
por: Kopacek, Cristiane, et al.
Publicado: (2020)

THU207 11-oxygenated Androgens Are Strongly Associated With Treatment Quality In Children With Congenital Adrenal Hyperplasia Due To 21-Hydroxylase Deficiency
por: Abawi, Ozair, et al.
Publicado: (2023)

Food Perception and Differences in Dietary Decision-Making in Youth With Congenital Adrenal Hyperplasia
por: Luo, Shan, et al.
Publicado: (2021)

Corrigendum: The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Pignatelli, Duarte, et al.
Publicado: (2020)

SAT-LB067 Mutational Spectrum Determines Subtle Adrenal Biosynthetic Defect in Non-Classical Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Mermejo, Livia, et al.
Publicado: (2019)

SAT-LB052 Intravenous Bisphosphonate Therapy in Children with Spinal Muscular Atrophy
por: Nasomyont, Nat, et al.
Publicado: (2019)

SAT-LB17 Triplication of SHOX Downstream Region in Mild Short Stature
por: Bunyan, David J, et al.
Publicado: (2020)

SAT-LB18 A Randomized Controlled Trial of Vosoritide in Children With Achondroplasia
por: Savarirayan, Ravi, et al.
Publicado: (2020)

Growth-Related Characteristics of Patients <18 Years of Age with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency (21OHD): Real World Evidence from the I-CAH Registry
por: Farrar, Mallory, et al.
Publicado: (2021)

Quality of Life in Men With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Verhees, Myrthe J. M., et al.
Publicado: (2021)

ODP394 Prevalence of Anxiety and Depressive Symptoms in Children and Adolescents with Congenital Adrenal Hyperplasia (CAH)
por: Jacob, Marianne, et al.
Publicado: (2022)

THU188 Clinical Conundrum: Salt Wasting Congenital Adrenal Hyperplasia With Paradoxical High Cortisol
por: Pillai, Chanthu
Publicado: (2023)

SAT-277 Re-Evaluation of the 17-Hydroxyprogesterone (17-OHP) Screening Threshold for Diagnosing Nonclassic Congenital Adrenal Hyperplasia (NCCAH) in the Era of Liquid Chromatography Tandem-Mass Spectrometry (LC-MS/MS)
por: Chesover, Alexander, et al.
Publicado: (2019)

Editorial: Management of Females with Congenital Adrenal Hyperplasia
por: González, Ricardo, et al.
Publicado: (2017)

Assisted Reproduction in Congenital Adrenal Hyperplasia
por: Chatziaggelou, Anastasios, et al.
Publicado: (2019)

Quality of Life in Children and Young People With Congenital Adrenal Hyperplasia in the United Kingdom - Nationwide Multicentre Assessment
por: Lawrence, Neil Richard, et al.
Publicado: (2021)

Cardiovascular Health in Children and Adolescents With Congenital Adrenal Hyperplasia Due to 21-Hydroxilase Deficiency
por: Improda, Nicola, et al.
Publicado: (2019)

Characteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Kocova, Mirjana, et al.
Publicado: (2022)

Adrenal Tumor Mimicking Non-Classic Congenital Adrenal Hyperplasia
por: Tsai, Wen-Hsuan, et al.
Publicado: (2020)

THU187 Genotype-Phenotype Correlation, Clinical Presentation And Feminizing Surgery In Children With Congenital Adrenal Hyperplasia Due To 21-Hydroxylase Deficiency: A Nationwide Multi-Center Study
por: Lind-Holst, Marie, et al.
Publicado: (2023)

PMON191 Current Management of Acute Adrenal Insufficiency Related Adverse Events in Children with Congenital Adrenal Hyperplasia- Results of an International Survey of Specialist Centres
por: Ali, Salma Rashid, et al.
Publicado: (2022)

SUN-281 Topiramate-Induced BMI Reduction in an Adolescent with Severe Obesity Associated with Classical Congenital Adrenal Hyperplasia
por: Seagroves, Amy, et al.
Publicado: (2019)

Morphologic and Molecular Characterization of Adrenals and Adrenal Rest Affected by Congenital Adrenal Hyperplasia
por: Kolli, Vipula, et al.
Publicado: (2021)

SAT-069 A Case of Congenital Hypoaldosteronism Due to Aldosterone Synthase Deficiency Misdiagnosed as Classic Congenital Adrenal Hyperplasia
por: Mallappa, Ashwini, et al.
Publicado: (2019)

Congenital Adrenal Hyperplasias Presenting in the Newborn and Young Infant
por: Balsamo, Antonio, et al.
Publicado: (2020)

SAT-LB047 Circulating IGF-1, MKRN3, and Kisspeptin in Girls during the Onset of Puberty
por: Yang, Fan
Publicado: (2019)

OR18-4 Crinecerfont (NBI-74788), a Novel CRF1 Receptor Antagonist, Lowers Adrenal Androgens and Precursors in Adolescents with Classic Congenital Adrenal Hyperplasia
por: Auchus, Richard, et al.
Publicado: (2022)

Congenital Adrenal Hyperplasia and Ehlers-Danlos Syndrome
por: Marino, Roxana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_glqggihem4s1q98cmcnigeiucd